We are live on ! Find out more
CYCN icon

Cyclerion Therapeutics
CYCN

41 hedge funds and large institutions have $11.5M invested in Cyclerion Therapeutics in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.25% less ownership

Funds ownership: 2.66% → 2.41% (-0.25%)

18% less funds holding

Funds holding: 50 → 41 (-9)

33% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 12

55% less capital invested

Capital invested by funds: $25.6M → $11.5M (-$14.1M)

67% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 12

Holders
41
Holders Change
-9
Holders Change %
-18%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
8
Reduced
12
Closed
12
Calls
$254K
Puts
–
Net Calls
+$254K
Net Calls Change
-$144K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$110K
2
DC
Diametric Capital
Massachusetts
+$43.4K
3
Jane Street
Jane Street
New York
+$41.8K
4
TSS
Two Sigma Securities
New York
+$39.1K
5
Prudential Financial
Prudential Financial
New Jersey
+$37.4K

Top Sellers

Rank Fund Capital Flow
1
PVI
Pura Vida Investments
New York
-$862K
2
IC
Ikarian Capital
Texas
-$585K
3
EP
Eversept Partners
New York
-$413K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$136K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$84.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Verition Fund Management
26
Verition Fund Management
Connecticut
$11K – – –
Group One Trading
27
Group One Trading
Illinois
$10K +$72 +5 +0.5%
TRCT
28
Tower Research Capital (TRC)
New York
$8K -$2.79K -195 -22%
DC
29
Davenport & Co
Virginia
$7K – – –
Morgan Stanley
30
Morgan Stanley
New York
$3K -$24.3K -1,696 -87%
HNWAG
31
High Net Worth Advisory Group
Florida
$1K – – –
Simplex Trading
32
Simplex Trading
Illinois
$1K +$2.44K +170 New
BNP Paribas Financial Markets
33
BNP Paribas Financial Markets
France
$174 +$29 +2 +14%
PVI
34
Pura Vida Investments
New York
– -$862K -38,825 Closed
IC
35
Ikarian Capital
Texas
– -$585K -26,373 Closed
EP
36
Eversept Partners
New York
– -$413K -18,598 Closed
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
– -$136K -6,112 Closed
Bank of New York Mellon
38
Bank of New York Mellon
New York
– -$74K -3,326 Closed
BFM
39
Boothbay Fund Management
New York
– -$56K -2,538 Closed
Dimensional Fund Advisors
40
Dimensional Fund Advisors
Texas
– -$50K -2,253 Closed
Two Sigma Investments
41
Two Sigma Investments
New York
– -$47K -2,120 Closed
UBS AM
42
UBS AM
Illinois
– -$11.3K -507 Closed
SC
43
Sawyer & Company
Massachusetts
– -$5K -205 Closed
UBS Group
44
UBS Group
Switzerland
– -$4K -182 Closed
Bank of America
45
Bank of America
North Carolina
– -$1.76K -123 -99%
Northwestern Mutual Wealth Management
46
Northwestern Mutual Wealth Management
Wisconsin
– -$72 -5 -83%
Wells Fargo
47
Wells Fargo
California
– +$14 +1 +5%
1
2

CYCN Hedge Fund Activity: Q2 2022 in Review

41 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Cyclerion Therapeutics (CYCN) for Q2 2022, worth a combined $11.5M — down 55% from $25.6M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of CYCN and 4 opened new positions — a net loss of 8 holders — while 12 trimmed existing stakes and 8 added.

The largest buyer was Renaissance Technologies, adding an estimated $110K. The largest seller was Pura Vida Investments, exiting entirely with an estimated $862K sold.

  • 41 institutional investors held Cyclerion Therapeutics (CYCN) as of Q2 2022, down from 50 in Q1 2022.
  • Funds reported $11.5M of Cyclerion Therapeutics stock for Q2 2022, down 55% quarter-over-quarter.
  • 4 funds opened new Cyclerion Therapeutics positions in Q2 2022 and 12 closed out, a net change of -8 holders.
  • The largest Cyclerion Therapeutics buyer in Q2 2022 was Renaissance Technologies, an estimated $110K added.
  • The largest Cyclerion Therapeutics seller in Q2 2022 was Pura Vida Investments, an estimated $862K sold.

Based on aggregated 13F filings for Q2 2022.